Oral Nitrite Trial for Hypertension and Metabolic Syndrome

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Metabolic Syndrome, Hypertension

In brief

The objective of the study is to investigate effects of inorganic sodium nitrite on the cardiometabolic and hormonal disturbances observed in a targeted population of overweight/obese adults with metabolic syndrome and hypertension, at risk for insulin resistance and endothelial dysfunction.

Key facts

Study ID
NCT02517697
Run by
Gladwin, Mark, MD
People needed
0
Starts
2020-10-01
Expected to finish
2021-04-13
Last updated by the study team
2021-04-19

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.